A detailed history of Huntington National Bank transactions in Chemo Centryx, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1 shares of CCXI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.0 - $51.99 $0 - $14,401
-277 Reduced 99.64%
1 $0
Q3 2022

Nov 07, 2022

SELL
$22.17 - $51.8 $15,385 - $35,949
-694 Reduced 71.4%
278 $14,000
Q2 2022

Aug 09, 2022

BUY
$15.36 - $27.51 $13,440 - $24,071
875 Added 902.06%
972 $24,000
Q1 2022

May 10, 2022

BUY
$22.22 - $39.12 $577 - $1,017
26 Added 36.62%
97 $2,000
Q4 2021

Jan 21, 2022

BUY
$18.38 - $40.5 $1,304 - $2,875
71 New
71 $3,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.